Position in KOD
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$1,118,744
+$572,715 QoQ
Shares Held
29,348
+50.3% QoQ
Ownership
0.047%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
8 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in KOD Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026FRANKLIN RESOURCES INC holds $7,057,408,835 across 166 Biotechnology names. KOD ranks #118 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,722,071 | $2,103,180,930 | |
| 2 | ASND |
Ascendis Pharma A/S
|
2,051,948 | $469,342,063 | |
| 3 | INSM |
INSMED Inc
|
2,617,251 | $427,972,880 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
1,958,940 | $370,337,604 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
551,132 | $246,102,477 | |
| 6 | BBIO |
BridgeBio Pharma, Inc.
|
2,438,925 | $181,114,568 | |
| 7 | ARGX |
Argenx SE
|
233,493 | $170,508,261 | |
| 8 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
470,390 | $155,637,935 |
All Filings in KOD
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,118,744 | 29,348 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $546,029 | 19,529 | Shares | Defined | 2026-02-11 | |
| 2024-03-31 | $170,218 | 32,361 | Shares | Defined | 2024-05-13 | |
| 2021-12-31 | $15,827,747 | 186,692 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $17,918,218 | 186,687 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $17,271,960 | 185,720 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $20,998,467 | 185,188 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $27,205,969 | 185,188 | Shares | Defined | 2021-02-10 | |
| No filing history on record for this holder in this stock. | ||||||